Search

Heron Therapeutics Inc

Lezárt

SzektorEgészségügy

0.28

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

0.26

Maximum

0.31

Fő mutatók

By Trading Economics

Bevétel

2.6M

-5.5M

Értékesítés

3M

38M

Egy részvényre jutó nyereség

-0.03

Profit margin

-14.573

Munkavállalók

128

EBITDA

2.1M

-5.5M

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 3.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-46M

51M

Előző nyitás

0.28

Előző zárás

0.28

Hangulat hírek alapján

By Acuity

20%

80%

20 / 339 Rangsor szerint Healthcare

Heron Therapeutics Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. szept. 22. 23:55 UTC

News

Roivant Sciences Ltd is higher in after-market trading following positive Phase 2 trial results for mosliciguat, showing significant improvements in pulmonary hypertension patients.

2026. szept. 22. 23:51 UTC

News

Itron Inc's stock is declining in after-market trading, despite the launch of its Riva IEC Grid Edge Portfolio in the Asia Pacific region.

2026. szept. 22. 23:50 UTC

News

Coeur Mining plans a record $158 million exploration investment for 2026, more than double 2025's budget, as shares rise in after-market trading.

2026. szept. 22. 23:41 UTC

Social Media
Event
News

NN, Inc. raised its 2026 net sales guidance to $470M-$490M and adjusted EBITDA to $58M-$68M, leading to a sharp after-market hours increase.

2026. szept. 22. 23:35 UTC

News

Tencent Music Entertainment Group's shares rose in after-market trading, maintaining a strong performance above the 20-day moving average since Tuesday's close.

2026. szept. 22. 23:35 UTC

News

Quest Diagnostics will release third-quarter results on October 22, 2026, and is modestly higher in after-market trading since Tuesday's close.

2026. szept. 22. 23:31 UTC

Correlated Moves
News

Dynex Capital Inc announced a public offering of 4.8M shares of preferred stock, expected to raise $120 million, with shares trading higher in after-market hours.

2026. szept. 22. 23:31 UTC

News

Peloton Interactive Inc. plans to launch the "Tread Flex" treadmill as part of its turnaround strategy, contributing to modest gains in after-market trading.

2026. szept. 22. 23:25 UTC

News

Domo Inc completes asset sale to Progress Software, rebranding as Huckleberry.ai, and is now debt-free with $221 million in cash, shares advancing in after-market trading.

2026. szept. 22. 23:21 UTC

Social Media
News

Meta's Muse AI app tops U.S. App Store, leading to after-market gains as analysts raise price targets to $820 and $796 amid strong user engagement.

2026. szept. 22. 23:10 UTC

News

Shares declined in after-market trading; implied volatility at yearly low.

2026. szept. 22. 23:10 UTC

News

General Electric Co is trading slightly higher in after-market hours, supported by a $170 billion commercial services backlog and strong pricing power.

2026. szept. 22. 23:10 UTC

News

RTX Corp received a $105.6 million contract modification from the U.S. Department of War for missile parts, with work expected to complete by August 31, 2027.

2026. szept. 22. 23:10 UTC

News

V2X Inc received a $231.8 million contract modification from the U.S. Air Force, raising total contract value to $594.2 million, boosting stock in after-market trading.

2026. szept. 22. 23:06 UTC

News

Home Depot announced a partnership with TP-Link to offer exclusive Tapo smart home security camera bundles in 500 stores and online, with shares roughly flat in after-market trading.

2026. szept. 22. 23:06 UTC

News

Microsoft will consider shareholder proposals at its annual meetings, following an agreement with activist Paul Chesser, and is trading higher in after-market hours.

2026. szept. 22. 23:06 UTC

News

General Motors Co is trading lower in after-market hours, having retraced from earlier gains and falling below its 20-day moving average.

2026. szept. 22. 23:06 UTC

News

Verizon Communications Inc. is seeing a modest increase in after-market trading, bolstered by the launch of a new 5G handset and expanded 6G research partnerships.

2026. szept. 22. 23:06 UTC

News

XRP has gained traction, supported by positive trading posts and recent performance in liquidity pools, despite pulling back from earlier session highs.

2026. szept. 22. 23:06 UTC

News

Eli Lilly's stock is higher in after-market trading as the company begins construction on a $6.5 billion facility for its oral GLP-1 drug, Foundayo.

2026. szept. 22. 23:05 UTC

News

Star Bulk Carriers is trading higher in after-market hours, rebounding from a dip, as Alexandros Pappas purchased $2.1 million in stock at $28.27 per share.

2026. szept. 22. 23:01 UTC

News

Intercontinental Exchange Inc. has launched a private credit reference data service for institutional clients, contributing to its gains in after-market trading.

2026. szept. 22. 23:01 UTC

News
Social Media

Brighthouse Financial's shares rose in after-market trading as Sixth Street reiterated its interest in acquiring the company amid regulatory delays with another buyer.

2026. szept. 22. 23:01 UTC

Social Media
News

CME Group plans to introduce Bitcoin Cash and Uniswap futures on October 19, pending regulatory approval, as its stock moves higher in after-market trading.

2026. szept. 22. 23:01 UTC

News

CF Industries Holdings Inc is advancing in after-market trading, recovering from recent declines amid concerns over a potential potash supply deal with Belarus.

2026. szept. 22. 23:01 UTC

Event
News

Worthington Enterprises reported Q1 fiscal 2027 net sales of $343.9 million and EPS of $0.87, exceeding expectations, driving the stock sharply higher in after-market trading.

2026. szept. 22. 23:01 UTC

Social Media
News

Sharp decline in revenues and net income leads to after-hours drop.

2026. szept. 22. 23:01 UTC

News

General Mills Inc's adjusted diluted EPS is projected between $3 and $3.20, with shares moving modestly higher in after-market trading.

2026. szept. 22. 23:01 UTC

News

Credit Acceptance Corporation appointed Shannon Wilson as Chief Human Resources Officer, effective September 28, 2026, contributing to an upward move in after-market trading.

2026. szept. 22. 23:01 UTC

News

Williams-Sonoma Inc's market capitalization is $27.41 billion, with the stock showing a notable increase in after-market trading, continuing a five-session positive trend.

Társak összehasonlítása

Árváltozás

Heron Therapeutics Inc Előrejelzés

Értékelési konszenzus

By TipRanks

Semleges

2 ratings

0

Vétel

2

Tartás

0

Eladás

Hangulat

By Acuity

20 / 339 Rangsor szerint Egészségügy

Hangulat hírek alapján

Nagyon erős bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag feletti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.